Back to Results
First PageMeta Content
Thousand Oaks / California / Pharmaceutical industry / Astellas Pharma / Pharmaceutical drug / Health / Pharmacology / Pharmaceutical sciences / Amgen


AMGEN AND ASTELLAS ANNOUNCE JAPAN ALLIANCE Innovative Joint Venture to Address Unmet Medical Needs of Patients in Japan THOUSAND OAKS, Calif., and TOKYO (May 29, 2013) – Amgen (NASDAQ:AMGN), the world’s largest indep
Add to Reading List

Document Date: 2013-05-28 22:34:50

Open Document

File Size: 76,64 KB

Share Result on Facebook

City

TOKYO / /

Company

AMGEN / Goldman Sachs & Co. / Astellas Pharma Inc. / UCB AMGEN / Morrison & Foerster LLP / Innovative Joint Venture / Tokyo Stock Exchange / /

Country

Japan / United States / /

Event

Business Partnership / Employment Change / FDA Phase / /

/

IndustryTerm

legislation affecting pharmaceutical pricing / biotechnology / cell culture systems / treatment of cardiovascular and bone diseases / healthcare cost containment / insurance plans / pharmaceutical / manufacturing plant / manufacturing capacity / pharmaceuticals / biotechnology pioneer / manufacturing problems / /

MedicalCondition

Gastric Cancer MET / Non-Hodgkin’s Lymphoma / cancer / kidney diseases / Acute Lymphoblastic Leukemia / bone diseases / infectious diseases / /

Organization

U.S. government / Securities and Exchange Commission / /

Person

Eiichi Takahashi / Robert A. Bradway / Yoshihiko Hatanaka / /

/

Position

financial advisor / chairman and chief executive officer / general manager / physician / global category leader / external legal counsel / president and CEO / /

Product

PCSK-9 / /

ProvinceOrState

California / /

SportsEvent

NHL / /

Technology

neuroscience / biotechnology / transplantation / /

URL

www.amgen.com / http /

SocialTag